Skip to main content
NCBI home page
Canadian Journal of Veterinary Research logoLink to Canadian Journal of Veterinary Research
. 1998 Jan;62(1):38–43.

The incidence of caseous lymphadenitis in Alberta sheep and assessment of impact by vaccination with commercial and experimental vaccines.

K Stanford 1, K A Brogden 1, L A McClelland 1, G C Kozub 1, F Audibert 1
PMCID: PMC1189440  PMID: 9442938

Abstract

In Alberta, caseous lymphadenitis (CLA) is one of the leading causes of lamb and mutton carcass condemnation. In this study, serologic results confirmed a high (50-94%) incidence of exposure to Corynebacterium pseudotuberculosis, the causative agent of CLA, in mature, unvaccinated sheep in southern Alberta. To assess the efficacy and impact of vaccination with 2 commercial (Glanvac-6 and Case-Vac) and 1 experimental (WC+ MDP-GDP) CLA vaccines, a series of 3 field trials in 3249 ewes and lambs was conducted in affected flocks from 1992-1996. Efficacy was assessed from the serological response to vaccination, prevalence and size of injection site reactions by treatment, and the incidence of CLA abscesses. Overall, agglutinating antibody titres to C. pseudotuberculosis in lambs vaccinated with WC+MDP-GDP and Case-Vac remained significantly elevated above nonvaccinated control lambs for the 12 mo period after the initial vaccination. Lambs vaccinated with the WC/MDP-GDP maintained higher titres (P < 0.06) than those vaccinated with Case-Vac for the period from 6 to 12 mo after vaccination. Agglutinating antibody titres for lambs vaccinated with Glanvac did not differ from those of controls at any point during the 12 mo period after vaccination. The number of injection site reactions was elevated in lambs vaccinated with Glanvac as compared to those vaccinated with WC+MDP-GDP but the size of injection site reactions did not significantly differ. Sheep vaccinated with WC+ MDP-GDP also had a reduced incidence of putative CLA abscesses, although confirmation of the presence of C. pseudotuberculosis was only successful in a small number of instances.

Full text

PDF
38

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Batey R. G. Frequency and consequence of caseous lymphadenitis in sheep and lambs slaughtered at a Western Australian abattoir. Am J Vet Res. 1986 Feb;47(2):482–485. [PubMed] [Google Scholar]
  2. Brogden K. A., Chedid L., Cutlip R. C., Lehmkuhl H. D., Sacks J. Effect of muramyl dipeptide on immunogenicity of Corynebacterium pseudotuberculosis whole-cell vaccines in mice and lambs. Am J Vet Res. 1990 Feb;51(2):200–202. [PubMed] [Google Scholar]
  3. Brogden K. A., Cutlip R. C., Lehmkuhl H. D. Comparison of protection induced in lambs by Corynebacterium pseudotuberculosis whole cell and cell wall vaccines. Am J Vet Res. 1984 Nov;45(11):2393–2395. [PubMed] [Google Scholar]
  4. Eggleton D. G., Haynes J. A., Middleton H. D., Cox J. C. Immunisation against ovine caseous lymphadenitis: correlation between Corynebacterium pseudotuberculosis toxoid content and protective efficacy in combined clostridial-corynebacterial vaccines. Aust Vet J. 1991 Oct;68(10):322–325. doi: 10.1111/j.1751-0813.1991.tb03088.x. [DOI] [PubMed] [Google Scholar]
  5. Ellis T. M., Sutherland S. S., Wilkinson F. C., Mercy A. R., Paton M. W. The role of Corynebacterium pseudotuberculosis lung lesions in the transmission of this bacterium to other sheep. Aust Vet J. 1987 Sep;64(9):261–263. doi: 10.1111/j.1751-0813.1987.tb15952.x. [DOI] [PubMed] [Google Scholar]
  6. Gates N. L., Everson D. O., Hulet C. V. Effects of thin ewe syndrome on reproductive efficiency. J Am Vet Med Assoc. 1977 Dec 15;171(12):1266–1267. [PubMed] [Google Scholar]
  7. Menzies P. I., Muckle C. A., Brogden K. A., Robinson L. A field trial to evaluate a whole cell vaccine for the prevention of caseous lymphadenitis in sheep and goat flocks. Can J Vet Res. 1991 Oct;55(4):362–366. [PMC free article] [PubMed] [Google Scholar]
  8. Menzies P. I., Muckle C. A. The use of a microagglutination assay for the detection of antibodies to Corynebacterium pseudotuberculosis in naturally infected sheep and goat flocks. Can J Vet Res. 1989 Jul;53(3):313–318. [PMC free article] [PubMed] [Google Scholar]
  9. Paton M. W., Mercy A. R., Sutherland S. S., Ellis T. M., Duda S. R. The effect of antibody to caseous lymphadenitis in ewes on the efficacy of vaccination in lambs. Aust Vet J. 1991 Apr;68(4):143–146. doi: 10.1111/j.1751-0813.1991.tb03158.x. [DOI] [PubMed] [Google Scholar]
  10. Paton M. W., Mercy A. R., Wilkinson F. C., Gardner J. J., Sutherland S. S., Ellis T. M. The effects of caseous lymphadenitis on wool production and bodyweight in young sheep. Aust Vet J. 1988 Apr;65(4):117–119. doi: 10.1111/j.1751-0813.1988.tb14429.x. [DOI] [PubMed] [Google Scholar]
  11. Pépin M., Pardon P., Marly J., Lantier F., Arrigo J. L. Acquired immunity after primary caseous lymphadenitis in sheep. Am J Vet Res. 1993 Jun;54(6):873–877. [PubMed] [Google Scholar]
  12. Renshaw H. W., Graff V. P., Gates N. L. Visceral caseous lymphadenitis in thin ewe syndrome: isolation of Corynebacterium, Staphylococcus, and Moraxella spp from internal abscesses in emaciated ewes. Am J Vet Res. 1979 Aug;40(8):1110–1114. [PubMed] [Google Scholar]
  13. Stoops S. G., Renshaw H. W., Thilsted J. P. Ovine caseous lymphadenitis: disease prevalence, lesion distribution, and thoracic manifestations in a population of mature culled sheep from western United States. Am J Vet Res. 1984 Mar;45(3):557–561. [PubMed] [Google Scholar]
  14. Sutherland S. S., Ellis T. M., Paton M. J., Mercy A. R. Serological response of vaccinated sheep after challenge with Corynebacterium pseudotuberculosis. Aust Vet J. 1992 Jul;69(7):168–169. doi: 10.1111/j.1751-0813.1992.tb07504.x. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Journal of Veterinary Research are provided here courtesy of Canadian Veterinary Medical Association

RESOURCES